Turini George A, Gjelsvik Annie, Renzulli Joseph F
Minimally Invasive Urology Institute, Division of Urology, Brown University, Providence, RI.
Department of Epidemiology, Brown University School of Public Health, Providence, RI.
Urology. 2017 Jun;104:122-130. doi: 10.1016/j.urology.2016.12.069. Epub 2017 Mar 16.
To determine if the quality of prescreening discussions has changed following release of the United States Preventive Services Task Force statement against prostate cancer screening.
This cross-sectional study used the 2012 and 2014 Behavioral Risk Factor Surveillance System surveys. Respondents were categorized based on the year in which they responded to the Behavioral Risk Factor Surveillance System Survey. Quality of prescreening discussion was operationalized as having discussed only advantages, only disadvantages, both advantages and disadvantages, or neither. Race/ethnicity, education level, income, insurance status, and having a prostate-specific antigen (PSA) level actually drawn after prescreening counseling served as confounders in our multivariate analysis.
Among 217,053 men in the analytic sample, 37% were told about only advantages of PSA screening compared to 30% of men who were advised about both advantages and disadvantages. Men who were told about neither advantages nor disadvantages were more likely to be Hispanic, not graduate high school, have low income, and not have insurance. Controlling for covariates, men in 2014 were significantly more likely to have undergone PSA testing without having discussed either advantages or disadvantages than men in 2012.
Comprehensive prescreening discussions about advantages and disadvantages of PSA testing are critical to informed decision making about prostate cancer screening. Disparities not only exist with regard to the quality of prescreening discussions that patients receive from their providers prior to PSA testing across categories of race/ethnicity, education, income, and insurance status, but these disparities became more substantial between 2012 and 2014. Further investigation is warranted to elicit more specific reasons behind these variations.
确定在美国预防服务工作组发布反对前列腺癌筛查声明后,预筛查讨论的质量是否发生了变化。
这项横断面研究使用了2012年和2014年行为危险因素监测系统调查。根据受访者对行为危险因素监测系统调查做出回应的年份进行分类。预筛查讨论的质量通过仅讨论优点、仅讨论缺点、优缺点都讨论或都未讨论来衡量。种族/民族、教育水平、收入、保险状况以及在预筛查咨询后实际进行前列腺特异性抗原(PSA)检测作为多变量分析中的混杂因素。
在分析样本中的217,053名男性中,37%的人仅被告知PSA筛查的优点,相比之下30% 的人同时被告知优缺点。既未被告知优点也未被告知缺点的男性更有可能是西班牙裔、未高中毕业、收入低且没有保险。在控制协变量后,2014年的男性在未讨论优缺点的情况下进行PSA检测的可能性显著高于2012年的男性。
关于PSA检测优缺点的全面预筛查讨论对于前列腺癌筛查的明智决策至关重要。患者在PSA检测前从医疗服务提供者那里获得的预筛查讨论质量在种族/民族、教育、收入和保险状况类别之间不仅存在差异,而且这些差异在2012年至2014年之间变得更加显著。有必要进行进一步调查以找出这些差异背后更具体的原因。